Skip to main navigation

News & Publications
Careers
Contact Us

About Nabriva
Pipeline & Research
for investors

Home
About Nabriva
- About Nabriva Overview
- Meet the Team
Pipeline & Research
- pipeline & research Overview
- Pleuromutilins Research
For Investors
News & Publications
Careers
Contact Us

Investors Center

Home / For Investors

Events & Presentations
Press Releases
Financial Performance
Share Performance
Shareholder Information
Corporate Governance
Email Alerts

Quarterly Reports

Annual Reports
Quarterly Reports
SEC Filings

Show all

2019 Close Open

Quarter

Press Release

10-Q

Transcript

Q1

Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

2018 Close Open

Quarter

Press Release

10-Q

Transcript

Q1

Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

Q2

Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

Q3

Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

2017 Close Open

Quarter

Press Release

10-Q

Transcript

Q1

Corrected - Nabriva Therapeutics Reports First Quarter 2017 Financial Results

Q2

Nabriva Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights

Q3

Nabriva Therapeutics Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

2016 Close Open

Quarter

Press Release

10-Q

Transcript

Q1

Nabriva Reports First Quarter 2016 Financial Results

Q2

Nabriva Reports Second Quarter 2016 Financial Results

Q3

Nabriva Reports Third Quarter 2016 Financial Results

Privacy Notice
Imprint
Disclaimer
Contact Us
Careers
Sitemap

© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 North Wall Quay, Dublin 1, Ireland

Privacy Notice
Imprint
Disclaimer
Contact Us
Careers
Sitemap

© Nabriva Therapeutics plc, Ireland Registration No. 599588, 25-28 Northwall Quay, Dublin 1, Ireland